Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa

Conditions

• Meningococcal Immunisation
• Healthy Volunteers

Interventions

• BIOLOGICAL: Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine
• BIOLOGICAL: Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
• BIOLOGICAL: Oral bivalent types 1 and 3; Poliomyelitis Vaccine (OPV)
• BIOLOGICAL: Pneumoccocal Vaccine
• BIOLOGICAL: Measles, Mumps, and Rubella Vaccine live (MMR)
• BIOLOGICAL: DTwP-HepB-Hib-IPV vaccine
• BIOLOGICAL: DTaP-IPV-Hib-HepB vaccine
• BIOLOGICAL: Hepatitis A vaccine
• BIOLOGICAL: Rotavirus vaccine
• BIOLOGICAL: Typhoid conjugate vaccine (TCV)
• BIOLOGICAL: Measles vaccine
• BIOLOGICAL: Varicella vaccine live
• BIOLOGICAL: Varicella vaccine live
• BIOLOGICAL: Measles, Mumps, and Rubella Vaccine live (MMR)
• BIOLOGICAL: Hepatitis A vaccine

Sponsor

Sanofi Pasteur, a Sanofi Company